Cargando…
Survival of Human Neurofibroma in Immunodeficient Mice and Initial Results of Therapy With Pirfenidone
Neurofibromatosis type I is a common tumor predisposing disease in humans. Surgical therapy can be applied only in selected patients with resectable masses. Hence, development of new therapies for this disease is urgent. We used human neurofibroma implants in mice with severe combined immunodeficien...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Hindawi Publishing Corporation
2004
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC548804/ https://www.ncbi.nlm.nih.gov/pubmed/15240917 http://dx.doi.org/10.1155/S1110724304308107 |